These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 10726264
1. Exposure, infection and immune responses to Schistosoma haematobium in young children. Woolhouse ME, Mutapi F, Ndhlovu PD, Chandiwana SK, Hagan P. Parasitology; 2000 Jan; 120 ( Pt 1)():37-44. PubMed ID: 10726264 [Abstract] [Full Text] [Related]
2. The effect of treatment on the age-antibody relationship in children infected with Schistosoma mansoni and Schistosoma haematobium. Mutapi F, Mduluza T, Ndhlovu PD. Mem Inst Oswaldo Cruz; 2002 Jan; 97 Suppl 1():173-80. PubMed ID: 12426616 [Abstract] [Full Text] [Related]
3. The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection. Mduluza T, Ndhlovu PD, Madziwa TM, Midzi N, Zinyama R, Turner CM, Chandiwana SK, Nyazema N, Hagan P. Mem Inst Oswaldo Cruz; 2001 Jan; 96 Suppl():157-64. PubMed ID: 11586443 [Abstract] [Full Text] [Related]
4. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe. Ndhlovu P, Cadman H, Vennervald BJ, Christensen NO, Chidimu M, Chandiwana SK. Parasite Immunol; 1996 Apr; 18(4):181-91. PubMed ID: 9223173 [Abstract] [Full Text] [Related]
5. Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria. Imai N, Rujeni N, Nausch N, Bourke CD, Appleby LJ, Cowan G, Gwisai R, Midzi N, Cavanagh D, Mduluza T, Taylor D, Mutapi F. Parasitology; 2011 Oct; 138(12):1519-33. PubMed ID: 21813042 [Abstract] [Full Text] [Related]
6. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity. Chisango TJ, Ndlovu B, Vengesai A, Nhidza AF, Sibanda EP, Zhou D, Mutapi F, Mduluza T. BMC Infect Dis; 2019 Mar 04; 19(1):219. PubMed ID: 30832614 [Abstract] [Full Text] [Related]
7. Application of immunodiagnostic assays: detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings. Al-Sherbiny MM, Osman AM, Hancock K, Deelder AM, Tsang VC. Am J Trop Med Hyg; 1999 Jun 04; 60(6):960-6. PubMed ID: 10403328 [Abstract] [Full Text] [Related]
8. Correlations between specific antibody levels and urine egg counts for Schistosoma haematobium. Ndhlovu PD, Woolhouse ME. Trans R Soc Trop Med Hyg; 1996 Jun 04; 90(3):324-5. PubMed ID: 8758095 [No Abstract] [Full Text] [Related]
9. Detection of circulating antigens in patients with active Schistosoma haematobium infection. Hassan MM, Medhat A, Makhlouf MM, Shata T, Nafeh MA, Osman OA, Deaf EA, Galal N, Fouad YM. Am J Trop Med Hyg; 1998 Aug 04; 59(2):295-301. PubMed ID: 9715950 [Abstract] [Full Text] [Related]
10. Circulating anodic antigen (CAA) levels in different age groups in a Zimbabwean rural community endemic for Schistosoma haematobium determined using the magnetic beads antigen-capture enzyme-linked immunoassay. Ndhlovu P, Cadman H, Gundersen S, Vennervald BJ, Friis H, Christensen NO, Mutasa G, Kaondera K, Mandaza G, Deelder AM. Am J Trop Med Hyg; 1996 May 04; 54(5):537-42. PubMed ID: 8644912 [Abstract] [Full Text] [Related]
11. Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium. Mitchell KM, Mutapi F, Mduluza T, Midzi N, Savill NJ, Woolhouse ME. PLoS Negl Trop Dis; 2014 May 04; 8(7):e3059. PubMed ID: 25079601 [Abstract] [Full Text] [Related]
14. Comparison of the circulating anodic antigen detection assay and urine filtration to diagnose Schistosoma haematobium infections in Mali. De Clercq D, Sacko M, Vercruysse J, Diarra A, Landouré A, vanden Bussche V, Gryseels B, Deelder A. Trans R Soc Trop Med Hyg; 1995 May 04; 89(4):395-7. PubMed ID: 7570876 [Abstract] [Full Text] [Related]
15. The antibody responses to adult-worm antigens of Schistosoma haematobium, among infected and resistant individuals from an endemic community in southern Ghana. Osada Y, Anyan WK, Boamah D, Otchere J, Quartey J, Asigbee JR, Bosompem KM, Kojima S, Ohta N. Ann Trop Med Parasitol; 2003 Dec 04; 97(8):817-26. PubMed ID: 14754494 [Abstract] [Full Text] [Related]
16. Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoni at the point-of-care in northeast Zimbabwe. Nausch N, Dawson EM, Midzi N, Mduluza T, Mutapi F, Doenhoff MJ. BMC Infect Dis; 2014 Mar 26; 14():165. PubMed ID: 24666689 [Abstract] [Full Text] [Related]
17. Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status. Milner T, Reilly L, Nausch N, Midzi N, Mduluza T, Maizels R, Mutapi F. Parasite Immunol; 2010 Mar 26; 32(11-12):710-21. PubMed ID: 21039611 [Abstract] [Full Text] [Related]
20. Evaluation of a novel rapid diagnostic test for Schistosoma haematobium based on the detection of human immunoglobulins bound to filtered Schistosoma haematobium eggs. Sheele JM, Kihara JH, Baddorf S, Byrne J, Ravi B. Trop Med Int Health; 2013 Apr 26; 18(4):477-84. PubMed ID: 23331870 [Abstract] [Full Text] [Related] Page: [Next] [New Search]